Bar-Or A - Search Results

1

A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples.

Belabani C, Rajasekharan S, Poupon V, Johnson T, Bar-Or A; CIHR/MSSC NET in Clinical Autoimmunity; Canadian Pediatric Demyelinating Disease Network. Belabani C, et al. J Immunol Methods. 2013 Jan 31;387(1-2):1-10. doi: 10.1016/j.jim.2012.08.002. Epub 2012 Aug 11. J Immunol Methods. 2013. PMID: 22917931

2

Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients.

Johnson TA, Shames I, Keezer M, Lapierre Y, Haegert DG, Bar-Or A, Antel J. Johnson TA, et al. Clin Immunol. 2010 Oct;137(1):15-20. doi: 10.1016/j.clim.2010.06.005. Clin Immunol. 2010. PMID: 20599429 Clinical Trial.

3

Differential responses of human microglia and blood-derived myeloid cells to FTY720.

Durafourt BA, Lambert C, Johnson TA, Blain M, Bar-Or A, Antel JP. Durafourt BA, et al. J Neuroimmunol. 2011 Jan;230(1-2):10-6. doi: 10.1016/j.jneuroim.2010.08.006. Epub 2010 Sep 9. J Neuroimmunol. 2011. PMID: 20826007

4

Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis.

Johnson TA, Lapierre Y, Bar-Or A, Antel JP. Johnson TA, et al. Arch Neurol. 2010 Dec;67(12):1449-55. doi: 10.1001/archneurol.2010.312. Arch Neurol. 2010. PMID: 21149809 Clinical Trial.

5

HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.

Disanto G, Magalhaes S, Handel AE, Morrison KM, Sadovnick AD, Ebers GC, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network. Disanto G, et al. Neurology. 2011 Mar 1;76(9):781-6. doi: 10.1212/WNL.0b013e31820ee1cd. Epub 2011 Feb 2. Neurology. 2011. PMID: 21288988 Free PMC article.

6

Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.

Johnson TA, Evans BL, Durafourt BA, Blain M, Lapierre Y, Bar-Or A, Antel JP. Johnson TA, et al. J Immunol. 2011 Jul 1;187(1):570-9. doi: 10.4049/jimmunol.1003823. Epub 2011 May 27. J Immunol. 2011. PMID: 21622858 Clinical Trial.

7

Comparison of polarization properties of human adult microglia and blood-derived macrophages.

Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, Bar-Or A, Antel JP. Durafourt BA, et al. Glia. 2012 May;60(5):717-27. doi: 10.1002/glia.22298. Epub 2012 Jan 30. Glia. 2012. PMID: 22290798

8

From bench to MS bedside: challenges translating biomarker discovery to clinical practice.

Rajasekharan S, Bar-Or A; CIHR/MSSC NET in Clinical Autoimmunity. Rajasekharan S, et al. J Neuroimmunol. 2012 Jul 15;248(1-2):66-72. doi: 10.1016/j.jneuroim.2012.01.006. Epub 2012 Feb 29. J Neuroimmunol. 2012. PMID: 22381245 Review.

9

Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.

Dhaunchak AS, Becker C, Schulman H, De Faria O Jr, Rajasekharan S, Banwell B, Colman DR, Bar-Or A; Canadian Pediatric Demyelinating Disease Group. Dhaunchak AS, et al. Ann Neurol. 2012 May;71(5):601-13. doi: 10.1002/ana.22693. Epub 2012 Apr 4. Ann Neurol. 2012. PMID: 22473675

10

Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program.

O'Mahony J, Bar-Or A, Arnold DL, Sadovnick AD, Marrie RA, Banwell B; Canadian Pediatric Demyelinating Disease Network. O'Mahony J, et al. J Child Neurol. 2013 Feb;28(2):184-97. doi: 10.1177/0883073812443006. Epub 2012 May 9. J Child Neurol. 2013. PMID: 22573735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters